CALSADA CRISPINA
SEC insider (Form 3/4/5 filer). CIK 0001606833. Chief Financial Officer at Regulus Therapeutics Inc. (RGLS). 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 25, 2025. Located in SAN DIEGO, CA.
Companies CALSADA CRISPINA has filed insider reports for
- Regulus Therapeutics Inc. (RGLS): Officer, Chief Financial Officer
CALSADA CRISPINA
CIK: 0001606833
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Regulus Therapeutics Inc.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 25, 2025RGLS
Regulus Therapeutics Inc.
DispositionDirect140.2K shares- - Jan 30, 2025RGLS
Regulus Therapeutics Inc.
AwardDirectStock Option (Right to Buy)
562.5K shares- - Jan 14, 2025RGLS
Regulus Therapeutics Inc.
SaleDirect5.1K shares at avg. $1.26$6K - Jan 13, 2025RGLS
Regulus Therapeutics Inc.
SaleDirect38.7K shares at avg. $1.26$49K - Jan 9, 2025RGLS
Regulus Therapeutics Inc.
AwardDirect62.5K shares at avg. $1.36$85K - Jan 9, 2025RGLS
Regulus Therapeutics Inc.
AwardDirect21K shares at avg. $1.30$27K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | Disposition | 140,228 | - | - | Direct |
| Jan 30, 2025 | RGLS Regulus Therapeutics Inc. | Award Stock Option (Right to Buy) | 562,500 | - | - | Direct |
| Jan 14, 2025 | RGLS Regulus Therapeutics Inc. | Sale | 5,088 | $1.26 | $6,427 | Direct |
| Jan 13, 2025 | RGLS Regulus Therapeutics Inc. | Sale | 38,716 | $1.26 | $48,906 | Direct |
| Jan 9, 2025 | RGLS Regulus Therapeutics Inc. | Award | 62,500 | $1.36 | $85,000 | Direct |
| Jan 9, 2025 | RGLS Regulus Therapeutics Inc. | Award | 21,000 | $1.30 | $27,300 | Direct |
1-6 of 6 transactions